Using MRI to Study Liver Cancer Treatment
Part of Cancer, Digestive system clinical trials.
This trial uses special MRI scans to learn more about liver cancer (hepatocellular carcinoma) before and during treatment with TACE or SIRT. It may help doctors better understand how the tumor responds to therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have or are suspected to have liver cancer (HCC)
- You are scheduled to receive TACE or SIRT treatment as part of your care
- You can have an MRI scan safely (no metal implants, pacemaker, or severe claustrophobia)
- You do not have a known allergy to gadolinium (a dye used in MRI)
- Your kidneys are working well enough (eGFR at least 30)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a quicker MRI screening approach for people with cirrhosis to look for liver cancer early. It may help make liver cancer checkups faster and easier while still finding cancers when they are small.
This trial tests a new type of MRI scan (hyperpolarized 13C-MRI) in people with liver cancer who are already receiving radiation therapy, atezolizumab (an immunotherapy), and bevacizumab (a targeted therapy). The goal is to see if the scan can help doctors better understand how the cancer responds to treatment.
This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.
This study is looking for blood markers that may help doctors learn how well TACE treatment is working for liver cancer. You need to be scheduled for TACE and have a follow-up scan to participate.
This trial uses a special type of MRI scan to see if doctors can predict how well a liver cancer treatment (called TACE) will work for you. The scan may help doctors understand your treatment response better.
This study tests a new type of MRI that can look at the liver in more detail. It compares images from people with liver cancer and healthy people to see if it can help doctors better understand or detect the disease.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.